SafetyDrugs, the safety database.
Solid. Sturdy. Secure.
Solid. Sturdy. Secure.
SafetyDrugs is the pharmacovigilance software that allows you to collect, manage, transmit and analyze adverse events from clinical studies
and post marketing surveillance, including literature cases, of all products: from drugs to medical devices, from vaccines to cosmetics.
The web-based application runs on Oracle database, our technology partner and leader in Relational Data Base Management System (RDBMS).
What is it?
SafetyDrugs is the safety database that simplifies your pharmacovigilance activities: suitable for collecting, managing, transmitting and analyzing all adverse events.
Why?
SafetyDrugs is more than a simple database:
it is the tool that helps your work and its management. Supplied with features and tools for you and your team.
How much?
SafetyDrugs is profitable for everyone:
it suits any reality, saving unnecessary costs. Build your database fitted to
real business needs.
Last news
How to calculate regulatory deadlines in a structured way with Chronisia
Find out how pharmaceutical regulatory deadlines (PSURs, DLPs, AIC renewals) are calculated and how to manage them in a structured way.
New FDA adverse event platform: what changes for pharmaceutical companies in pharmacovigilance data management
AEMS is the new FDA platform for adverse event data. It does not change submission processes, but increases data accessibility, making quality and structure more critical.
ICSR Submission to FDA: ICH E2B(R3) becomes mandatory from 1 April 2026
From 1 April 2026, ICSR submissions to the FDA must be sent in ICH E2B(R3) format. Learn what changes for pharmacovigilance systems and FDA ESG submissions.
They chose SafetyDrugs…
